OTC:INSD Long Term Shareholder Notice: Investigation of Potential Wrongdoing at Instadose Pharma Corp.

An investigation on behalf of current long term investors in Instadose Pharma Corp. (OTC:INSD) shares over possible breaches of fiduciary duty by certain officers and directors was announced.

Logo

San Diego, CA -- (SBWire) -- 04/22/2022 --An investigation was announced for long-term investors in shares of Instadose Pharma Corp. (OTC: INSD) concerning potential breaches of fiduciary duties by certain directors and officers of Instadose Pharma Corp. f/k/a Mikrocoze, Inc.

Investors who are current long term investors in Instadose Pharma Corp. (OTC: INSD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in OTC: INSD stocks follows a lawsuit filed against Instadose Pharma Corp. over alleged securities laws violations. The investigation on behalf of current long term investors in OTC: INSD stocks, concerns whether certain Instadose Pharma directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Eastern District of Virgina the plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose that Instadose had performed inadequate due diligence into the Business Combination and/or ignored significant red flags associated with Instadose Canada, that Instadose's internal controls and policies were inadequate to detect and/or prevent impermissible trading activity by control persons of the Company, that the foregoing subjected Instadose to a heightened risk of regulatory scrutiny and enforcement action, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instadose Pharma Corp. (OTC: INSD) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Media Relations Contact

Christopher Clausen
Shareholders Foundation
1-858-779-1554
https://www.shareholdersfoundation.com/

View this press release online at: http://rwire.com/1356531